ATMPs: Opportunities and Challenges | PDA’s ATMP Conference 2018

Earlier this month, I attended the PDA’s 10th annual Conference on Advanced Therapy Medicinal Products (ATMPs) in Amsterdam. Over the past ten years, the conference has provided a forum to discuss opportunities and challenges in the space. The topics covered were wide-ranging – from R&D and manufacturing best practice right through to the clinical application of ATMPs.

Read More
Synthace Named a 2018 Cool Vendor in Life Sciences by Gartner

Synthace Ltd., the company behind the leading cloud software platform for automating and improving the success rate of biological research and development, today announced it has been recognised in Gartner Inc.'s "Cool Vendors in Life Sciences" report published on June 6, 2018. The companies named in this report represent a look into the new and innovative vendors, products and services in the global Life Sciences market.

Read More
Synthace Expert Interviews: Cell and Gene Therapies with Dr Damian Marshall

Damian Marshall is the director of new and enabling technologies at the Cell and Gene Therapy Catapult and has almost 20 years of industrial experience gained working for SME’s and large companies. He is responsible for providing vision, expertise and leadership to a team of ~60 scientists working with a wide range of cell and gene therapy developers. Together they are addressing some of the fundamental challenges in the field, developing novel cell and gene therapy manufacturing processes and implementing technologies for advanced product characterisation.

Read More